Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer

被引:10
|
作者
Kleinveld, HA
Andersson, NE
Van Voorthuizen, H
Den Hartog, J
De Groot, PG
机构
[1] Atrium Med Ctr, Dept Clin Chem & Hematol, NL-6401 CX Heerlen, Netherlands
[2] Chromogenix AB, Molndal, Sweden
[3] Nodia BV, Amsterdam, Netherlands
[4] Univ Hosp, Cent Diagnost Lab, Utrecht, Netherlands
关键词
chromogenic substrate; evaluation; factor VIII assay; hemophilia; STA automated-coagulation analyzer;
D O I
10.1080/00365519950185526
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study was aimed at evaluating the performance of a chromogenic factor VIII assay on STA, an automated coagulation analyzer. Additionally, a correlation study was conducted with an aPTT-based one-stage factor VIII clotting assay. Throughout the study the performance of the chromogenic assay was tested in two ranges of factor VIII activity: al high range with activity between 20% and 150% and a low range with activity below 20%. Inter-assay coefficient of variation ranged from 1.9% to 8.9% and intra-assay coefficient of variation from 0.5% to 11.4%, depending on factor VIII concentration. Day-today reproducibility was tested over a 5-day period; between-day imprecision ranged from 7.1% to 9.4%. The chromogenic factor VIII assay showed a good correlation with the clotting assay ire both ranges. The correlation coefficients were 0.924 and 0.792 for the high and low range, respectively. A statistically significant difference in mean values was observed in the high range (p < 0.0001). Comparison between the chromogenic assay on STA versus on microplates showed a high correlation (0.991), which was highly significant (p < 0.0001). In conclusion, the chromogenic assay for factor VIII on STA shows good analytical performance. It correlates well with the one-stage factor VIII clotting assay, although significant differences between individual samples occur. Probably these are partly related to differences in measurement principle and standardization. Altogether, this precise and rapid assay is suitable for determination of factor VIII by an automated procedure.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [31] Coagulation factor VIII: structure and stability
    Wang, W
    Wang, YJ
    Kelner, DN
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 259 (1-2) : 1 - 15
  • [32] Blood coagulation factor VIII: An overview
    Bhopale, GM
    Nanda, RK
    JOURNAL OF BIOSCIENCES, 2003, 28 (06) : 783 - 789
  • [33] Blood coagulation factor VIII: An overview
    G. M. Bhopale
    R. K. Nanda
    Journal of Biosciences, 2003, 28 : 783 - 789
  • [34] AUTOMATED SIMULTANEOUS COAGULATION TESTING WITH A CENTRIFUGAL ANALYZER
    DUNIKOSKI, LK
    KIEFER, L
    BLOOD, 1977, 50 (05) : 265 - 265
  • [35] EVALUATION OF A NEW UNIQUE AUTOMATED COAGULATION ANALYZER
    JOHNSTON, M
    ANDREW, M
    BLOOD, 1993, 82 (10) : A594 - A594
  • [36] DETERMINATION OF FACTOR-VIII COAGULATION ANTIGEN IN FACTOR-VIII CONCENTRATES BY USE OF AN INHIBITOR TEST
    IM, T
    HINTZ, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-1 (01): : 124 - 126
  • [37] Paediatric reference intervals for common coagulation assays in Chinese children as performed on the STA-R coagulation analyzer
    Liu, Junjie
    Dai, Yanpeng
    Yuan, Enwu
    Li, Yushan
    Wang, Quanxian
    Wang, Linkai
    Su, Yanhua
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (05) : 697 - 701
  • [38] Molecular defects in coagulation Factor VIII and their impact on Factor VIII function
    Saenko, EL
    Ananyeva, N
    Kouiavskaia, D
    Schwinn, H
    Josic, D
    Shima, M
    Hauser, CAE
    Pipe, S
    VOX SANGUINIS, 2002, 83 (02) : 89 - 96
  • [39] ON THE NECESSITY TO STANDARDIZE THE METHODS FOR STUDYING FACTOR-VIII COAGULATION ACTIVITY
    TARASOVA, LN
    PLATONOVA, GK
    LABORATORNOE DELO, 1988, (11): : 3 - 7
  • [40] Risperidone but not sertraline increases activity of coagulation factor VIII in clinical settings
    Dejanovic, S. Djukic
    Milovanovic, D.
    Folic, M.
    Djurdjevic, P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S245 - S246